RFK Jr. floats the idea of barring government scientists from publishing in leading medical journals due to “corruption”

Lou Weisbach tells us about his plan to raise $750 billion for the American Center for Cures

For nearly 25 years, business executive Lou Weisbach and urologist Richard J. Boxer have argued that finding the money to finance the cures for devastating diseases is not as difficult as it appears. To start finding the cures, the U.S. Department of the Treasury needs to issue some bonds—$750 billion worth. Next, you hire CEOs—one...

June 20, 2025

Vol.51 No.24

By Otis W. Brawley and Paul Goldberg

Clinical Roundup

Study of retifanlimab in squamous cell carcinoma meets primary endpoint of PFS

Primary results from the phase III POD1UM-303/InterAACT 2 trial of retifanlimab (Zynyz), a humanized monoclonal antibody targeting programmed death receptor-1, in combination with carboplatin and paclitaxel (platinum-based chemotherapy) in adult patients with inoperable locally recurrent or metastatic squamous cell carcinoma of the anal cancer who have not been previously treated with systemic chemotherapy, were published in The Lancet.

June 20, 2025

Vol.51 No.24

Capitol Hill

Senators slam Bhattacharya for deflecting responsibility for NIH cuts, upheaval
Susan Collins: Trump’s 40% cut is “so disturbing”

In a 96-minute hearing in front of the Senate Appropriations Committee on the Trump administration’s budget, senators slammed NIH Director Jay Bhattacharya for not taking responsibility for the funding cuts to research and upheaval at NIH.

June 13, 2025

Vol.51 No.23

By Claire Marie Porter

Cancer Policy

In “Bethesda Declaration,” NIH employees, Nobel laureates say Bhattacharya is favoring politics over U.S. science, health

NIH Director Jayanta Bhattacharya “prioritizes political momentum over human safety and faithful stewardship of public resources,” a group of Nobel laureates and over 300 NIH employees wrote in a letter.

Kennedy: “We’re going to end the war at FDA against alternative medicine”

HHS Secretary Robert Kennedy Jr. asserted that under his leadership, FDA will “end the war” against alternative medicine.

Samir S. Taneja named head of Northwell Health’s urology service line

Samir S. Taneja was selected to lead Northwell Health’s urology service line. He was appointed senior vice president, Northwell’s system chair of urology, and chair of the Smith Institute for Urology at Northwell Health.

June 13, 2025

Vol.51 No.23

RFK Jr. floats the idea of barring government scientists from publishing in leading medical journals due to “corruption”

YOU MAY BE INTERESTED IN

Lou Weisbach tells us about his plan to raise $750 billion for the American Center for Cures

Study of retifanlimab in squamous cell carcinoma meets primary endpoint of PFS

Senators slam Bhattacharya for deflecting responsibility for NIH cuts, upheaval
Susan Collins: Trump’s 40% cut is “so disturbing”

In “Bethesda Declaration,” NIH employees, Nobel laureates say Bhattacharya is favoring politics over U.S. science, health

Kennedy: “We’re going to end the war at FDA against alternative medicine”

Samir S. Taneja named head of Northwell Health’s urology service line

Renew today!

Subscriber content

Never miss an issue!

Login

RFK Jr. floats the idea of barring government scientists from publishing in leading medical journals due to “corruption”

YOU MAY BE INTERESTED IN

Lou Weisbach tells us about his plan to raise $750 billion for the American Center for Cures

Study of retifanlimab in squamous cell carcinoma meets primary endpoint of PFS

Senators slam Bhattacharya for deflecting responsibility for NIH cuts, upheavalSusan Collins: Trump’s 40% cut is “so disturbing”

In “Bethesda Declaration,” NIH employees, Nobel laureates say Bhattacharya is favoring politics over U.S. science, health

Kennedy: “We’re going to end the war at FDA against alternative medicine”

Samir S. Taneja named head of Northwell Health’s urology service line

Never miss an issue!

Login

Senators slam Bhattacharya for deflecting responsibility for NIH cuts, upheaval
Susan Collins: Trump’s 40% cut is “so disturbing”